Condensed IP

This episode concerns the United States Court of Appeals for the Federal Circuit's opinion in the case of Causam Enterprises, Inc. v. ecobee Technologies ULC, decided on October 15, 2025. The core issue is an appeal from a decision by the Patent Trial and Appeal Board (Board), which had ruled that several claims of Causam's U.S. Patent No. 10,394,268 were unpatentable due to obviousness following an inter partes review (IPR) initiated by ecobee. The court addresses two main arguments raised by Causam: first, a constitutional challenge concerning the Board's failure to determine the patent's true owner, which the court rejects on the grounds of third-party standing; and second, a challenge to the Board's construction of a key claim limitation regarding the generation of measurement and verification data. Ultimately, the Federal Circuit affirmed the Board's decision, finding no reversible error in either the ownership handling or the claim construction, thereby upholding the finding that the challenged claims are unpatentable.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This opinion from the United States Court of Appeals for the Federal Circuit, dated October 15, 2025, concerns the case of Inland Diamond Products Co. v. Cherry Optical Inc. The court addresses an appeal from the U.S. District Court for the Eastern District of Wisconsin, which had granted summary judgment that Inland’s asserted patent claims were invalid for obviousness based on the doctrine of issue preclusion following previous inter partes reviews (IPRs). The Federal Circuit determined that the district court erred by applying issue preclusion to facts found by the Patent Trial and Appeal Board (Board) under a lower standard of proof (preponderance) than the higher standard (clear and convincing evidence) required in district court invalidity proceedings, citing precedent from the ParkerVision and Kroy cases. Consequently, the appellate court vacates the district court's judgment and remands the case for proper analysis, emphasizing that any future summary judgment must be based on evidence presented in court under the clear and convincing standard, not on the Board’s prior findings.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This opinion from the United States Court of Appeals for the Federal Circuit, dated October 15, 2025, concerns the patent infringement case of Brita LP v. International Trade Commission (ITC). The court is reviewing Brita's appeal of an ITC decision that found certain claims of Brita's U.S. Patent No. 8,167,141 invalid. Specifically, the patent relates to gravity flow filter media designed to remove contaminants, defined by a metric called the Filter Rate and Performance (FRAP) factor. The Federal Circuit ultimately affirms the ITC's decision, ruling that the patent claims are invalid for lack of written description and lack of enablement because the patent only adequately described carbon-block filters and failed to show possession or teach how to make non-carbon-block filters capable of achieving the required FRAP factor.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This episode is about a United States Court of Appeals for the Federal Circuit opinion, decided on October 3, 2025, concerning the case of US Inventor, Inc. v. United States Patent and Trademark Office (PTO). The core issue of the appeal was whether the plaintiffs-appellants, US Inventor, Inc. and National Small Business United, had standing to sue the PTO for denying their petition for rulemaking. This petition sought to limit the PTO’s discretionary authority to institute inter partes review (IPR) and post-grant review (PGR) proceedings under the America Invents Act (AIA). The Federal Circuit affirmed the district court’s dismissal, concluding that the appellants lacked associational standing because the alleged injury—the increased risk of patent cancellation—was based on a highly speculative chain of future events involving third parties. Consequently, the court found that the plaintiffs failed to demonstrate a non-speculative injury in fact required for standing under Article III of the U.S. Constitution.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This episode concerns a decision from the United States Court of Appeals for the Federal Circuit regarding a patent infringement case, Rex Medical, L.P. v. Intuitive Surgical, Inc. The core issues addressed are damages, infringement, and patent validity of U.S. Patent No. 9,439,650, which relates to surgical stapling systems. The Federal Circuit ultimately affirmed the district court’s rulings, specifically upholding the exclusion of Rex Medical's damages expert testimony due to a failure to apportion the value of a prior license agreement. Consequently, the court affirmed the Judgment as a Matter of Law (JMOL) reducing the jury's $10 million damages award to nominal damages of $1 because Rex failed to provide sufficient evidence to support the higher amount. Finally, the court denied Intuitive Surgical's cross-appeal arguments related to non-infringement and the invalidity of the patent for lack of written description.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This episode is about an opinion from the United States Court of Appeals for the Federal Circuit, decided on September 30, 2025, concerning a complex intellectual property dispute between Focus Products Group International, LLC (and several related entities, collectively Appellees) and Kartri Sales Co., Inc. and Marquis Mills, International, Inc. (Appellants). The case centers on allegations that the Appellants infringed several utility patents, the HOOKLESS® trademark, the EZ ON trademark, and the trade dress associated with the Appellees' "hookless" shower curtains. The Federal Circuit partially affirmed the denial of motions to transfer venue and an "unclean hands" defense, but also reversed key findings of patent and trademark infringement and vacated the determinations on trade dress infringement, willful infringement, and the awarded attorneys' fees, remanding the case for further proceedings. The court's decision hinged on specific interpretations of patent claims, issues of trademark standing, and the functionality of the asserted trade dress features.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This episode concerns a decision from the United States Court of Appeals for the Federal Circuit. The court opinion, Apex Bank v. CC Serve Corp., decided on September 25, 2025, addresses an appeal from the Trademark Trial and Appeal Board regarding the likelihood of confusion between the ASPIRE mark used by CC Serve and the proposed ASPIRE BANK marks of Apex Bank. The Federal Circuit affirmed-in-part, vacated-in-part, and remanded the case, specifically upholding the Board's finding of high similarity between the parties' services (DuPont factor two) but vacating the findings on third-party use and overall mark similarity (DuPont factors six and one) due to the Board’s overly narrow scope of services considered. 

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This episode concerns an opinion from the United States Court of Appeals for the Federal Circuit regarding the case of Finesse Wireless LLC v. AT&T Mobility LLC and others. The court addresses an appeal by the defendants, AT&T and Nokia, against a district court's denial of Judgment as a Matter of Law (JMOL) regarding the noninfringement of U.S. Patent Nos. 7,346,134 and 9,548,775, which relate to methods for mitigating intermodulation product interference in radios. The Federal Circuit ultimately found that the jury's verdict of infringement for both patents was not supported by substantial evidence, particularly pointing to contradictory expert testimony regarding the patented methods. Consequently, the court reversed the denial of JMOL for noninfringement of all asserted claims and vacated the substantial damages award of over $166 million. The ruling details the technical reasons for noninfringement, focusing on the lack of evidence that the accused radios performed key claim limitations in both patents.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This opinion from the United States Court of Appeals for the Federal Circuit concerns a patent infringement appeal case, Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc. The appeal concerns the Patent Trial and Appeal Board's (PTAB) final written decision holding claims of Bayer's U.S. Patent No. 10,828,310, which describes methods using rivaroxaban and aspirin to reduce cardiovascular risk, unpatentable. The Court affirms-in-part and vacates-in-part the PTAB's decision, specifically upholding the unpatentability of claims 1–4, but vacating the judgment for claims 5–8 due to an incorrect claim construction of the term "first product." The Court also determined that the phrase "clinically proven effective" did not make the claims patentable because it lacked a necessary "functional relationship" with the claimed method. Furthermore, the Court found the PTAB provided sufficient rationale for combining prior art references, Foley and Plosker, and dismissed Bayer's argument about unexpected results because the evidence lacked the required nexus to the claimed invention's merits.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

This opinion concerns an appeal from a district court ruling in a patent infringement case between Magēmā Technology LLC and Phillips 66. Magēmā Technology, which holds a patent for desulfurizing heavy marine fuel oil (HMFO), sued Phillips 66 for infringement. The core issue on appeal concerns Phillips 66's improper and prejudicial argument at trial that ISO 8217 standards required actual testing data for fuel compliance, despite previously telling Magēmā that such testing was dangerous and estimates (using the Riazi Formula) would suffice. The Federal Circuit reversed the denial of a new trial, finding that the jury's non-infringement verdict could have been influenced by Phillips 66's misleading arguments, and also upheld the district court's construction of the term "HMFO." The case is now remanded for a new trial, where Phillips 66 is forbidden from making the aforementioned actual-testing argument.

This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.